TY - JOUR
T1 - Aberrant Proliferation in CXCR7+ Endothelial Cells via Degradation of the Retinoblastoma Protein
AU - Totonchy, Jennifer E.
AU - Osborn, Jessica M.
AU - Botto, Sara
AU - Clepper, Lisa
AU - Moses, Ashlee V.
PY - 2013/7/23
Y1 - 2013/7/23
N2 - Angiogenesis is a critical factor in the growth and dissemination of solid tumors. Indeed, tumor vasculature is abnormal and contributes to the development and spread of malignancies by creating a hostile microenvironment. The alternative SDF-1/CXCL12 receptor, CXCR7, is frequently and specifically expressed in tumor-associated vessels. In this study, we examine the role of endothelium-expressed CXCR7 in tumor vascular dysfunction by specifically examining the contribution of CXCR7 to endothelial cell (EC) proliferation. We demonstrate that CXCR7 expression is sufficient to drive post-confluent growth in EC cultures. Further, we provide a novel mechanism for CXCR7-mediated proliferation via proteasomal degradation of the tumor suppressor protein Rb. These findings identify a heretofore unappreciated role for CXCR7 in vascular dysfunction and confirm this receptor as a plausible target for anti-tumor therapy.
AB - Angiogenesis is a critical factor in the growth and dissemination of solid tumors. Indeed, tumor vasculature is abnormal and contributes to the development and spread of malignancies by creating a hostile microenvironment. The alternative SDF-1/CXCL12 receptor, CXCR7, is frequently and specifically expressed in tumor-associated vessels. In this study, we examine the role of endothelium-expressed CXCR7 in tumor vascular dysfunction by specifically examining the contribution of CXCR7 to endothelial cell (EC) proliferation. We demonstrate that CXCR7 expression is sufficient to drive post-confluent growth in EC cultures. Further, we provide a novel mechanism for CXCR7-mediated proliferation via proteasomal degradation of the tumor suppressor protein Rb. These findings identify a heretofore unappreciated role for CXCR7 in vascular dysfunction and confirm this receptor as a plausible target for anti-tumor therapy.
UR - http://www.scopus.com/inward/record.url?scp=84880743712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880743712&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0069828
DO - 10.1371/journal.pone.0069828
M3 - Article
C2 - 23894550
AN - SCOPUS:84880743712
SN - 1932-6203
VL - 8
JO - PloS one
JF - PloS one
IS - 7
M1 - e69828
ER -